Matches in Wikidata for { <http://www.wikidata.org/entity/Q64636779> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64636779 description "clinical trial" @default.
- Q64636779 description "ensayu clínicu" @default.
- Q64636779 description "klinisch onderzoek" @default.
- Q64636779 description "клінічне випробування" @default.
- Q64636779 name "Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)" @default.
- Q64636779 type Item @default.
- Q64636779 label "Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)" @default.
- Q64636779 prefLabel "Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)" @default.
- Q64636779 P1050 Q64636779-5C859279-1A54-4600-8A0E-65B129DE2296 @default.
- Q64636779 P1050 Q64636779-7F87376D-3187-49AC-8673-6F4935654C97 @default.
- Q64636779 P1050 Q64636779-E7C563D8-19CE-4115-B81A-0A3B643BC174 @default.
- Q64636779 P1132 Q64636779-683B3657-DF35-43FB-9FAB-7D27CB602B80 @default.
- Q64636779 P1476 Q64636779-6BB74D40-8053-4BAA-A7E5-AC5777D4C620 @default.
- Q64636779 P17 Q64636779-AD829C27-84BD-4622-9207-31E27163ADB7 @default.
- Q64636779 P17 Q64636779-EADC57B1-F7DD-497A-838F-8E890B74B596 @default.
- Q64636779 P2899 Q64636779-37B955EB-2F78-4A40-9594-4B4B9C5F5F71 @default.
- Q64636779 P3098 Q64636779-63240D3D-DAD9-41DA-89EC-58B6E63AA5D9 @default.
- Q64636779 P31 Q64636779-3ABE4013-EBCD-4840-963F-8F12AA72F2A3 @default.
- Q64636779 P580 Q64636779-BABAD9BB-F5CF-4A0E-83F2-E15948078444 @default.
- Q64636779 P582 Q64636779-AE39C697-DAE9-4560-B878-6E00BF05666B @default.
- Q64636779 P6099 Q64636779-14D86C0C-B063-4342-A9D9-FA531B088EC5 @default.
- Q64636779 P6153 Q64636779-47B73396-2E52-4E0E-8974-D28445E7F1B4 @default.
- Q64636779 P6153 Q64636779-519DFA66-15E0-4529-A5FB-EBC382CB7C18 @default.
- Q64636779 P8363 Q64636779-0ECF02CF-3DEE-4737-A8A6-F6A2667F4CBA @default.
- Q64636779 P1050 Q179630 @default.
- Q64636779 P1050 Q29496 @default.
- Q64636779 P1050 Q5445 @default.
- Q64636779 P1132 "+74" @default.
- Q64636779 P1476 "An Open-label, Randomized, Phase 2, Parallel, Dose-Ranging, Multicenter Study of Sotatercept for the Treatment of Patients With Anemia and Low or Intermediate-1 Risk Myelodysplastic Syndromes or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)" @default.
- Q64636779 P17 Q142 @default.
- Q64636779 P17 Q30 @default.
- Q64636779 P2899 "+18" @default.
- Q64636779 P3098 "NCT01736683" @default.
- Q64636779 P31 Q30612 @default.
- Q64636779 P580 "2012-11-28T00:00:00Z" @default.
- Q64636779 P582 "2018-04-30T00:00:00Z" @default.
- Q64636779 P6099 Q42824440 @default.
- Q64636779 P6153 Q2944818 @default.
- Q64636779 P6153 Q30270654 @default.
- Q64636779 P8363 Q78089383 @default.